Multidisciplinary Perspectives on Saving Sight – The Expanding Role of the Optometrist in Retinal Disease Care

Register here if you’re already logged in

Otherwise, register here

Date: May 31, 2023

Time: 8:00 PM - 9:00 PM ET

Overview:

Vascular endothelial growth factor (VEGF) inhibitors have a short duration of effect, and frequent intravitreal injections are needed to treat neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). In this program, expert faculty will address current challenges in treating these eye diseases with VEGF inhibitors and review clinical trials that aim to address the gaps in current therapy. They will also discuss the expanding role of optometrists in managing these patients.

Target audience:

This online educational activity is directed toward optometrists, ophthalmologists and other health care professionals who are involved in the management of patients with nAMD and DME.

Learning objectives:

• Describe the substantial clinical burden often associated with traditionally used vascular endothelial growth factor (VEGF) inhibitors for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)

• Evaluate the most recent efficacy and safety clinical trial data surrounding novel agents with unique mechanisms of action (MOAs) for nAMD and DME treatment

• Identify the responsibilities of optometrists who are managing patients with nAMD or DME

• Design an effective multidisciplinary care approach between optometrists and ophthalmologists to provide optimal outcomes for nAMD and DME patients

Benefits of Attending:

• Review the latest clinical trial results supporting the use of novel therapies aimed at treating nAMD and DME
• Discuss the expanding roles of optometrists who are managing nAMD or DME
• Learn about emerging agents and delivery methods for treating nAMD and DME from expert faculty

Hot Topics:

• Review the most recent efficacy and safety clinical trial data for novel agents with unique mechanisms of action (MOAs) for nAMD and DME
• Examine novel delivery methods for agents used to treat patients with nAMD and DME
• Design an effective multidisciplinary care approach between optometrists and ophthalmologists to provide optimal outcomes for nAMD and DME patients

Coming Soon!

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible companies to disclose.

PER^® mitigated all conflicts of interest (COI) for faculty, staff, and planners prior to the start of this activity by using a multistep process.